Bacterial decontamination of blood stem cell apheresis products

Journal of Clinical Apheresis

Volumn 13, Issue 3, 1998, Pages 103-107

  Gagnon, J Antony ^a   Porter, K ^b   Guerin D ^a   Glück, Stefan ^a,b,c  

^a Laurentian Universtiy   (Canada)

^b Northeastern Ontario Regional Cancer Centre   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Autotransplantation; Bacterial contamination; High dose chemotherapy; In vitro antibiotics; Pheresis product

Indexed keywords

ANTIBIOTIC AGENT; CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; APHERESIS; ARTICLE; BACTERIOLOGY; BACTERIUM CONTAMINATION; BLOOD; CONTROLLED STUDY; DISINFECTION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BLOOD COMPONENT REMOVAL; BLOOD-BORNE PATHOGENS; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; NEOPLASMS; TRANSPLANTATION, AUTOLOGOUS;

EID: 0031734032     PISSN: 07332459     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-1101(1998)13:3<103::AID-JCA2>3.0.CO;2-G     Document Type: Article

References (34)

1. ABMTR: Current Status of Blood and Marrow Transplantation, Statistical Centre, Medical College of Wisconsin, Milwaukee, 1996.
2. Antman KH, Rowlings PA, Vaughan WP, et al: High-dose chemotherapy with autologous haematopoietic stem-cell support for breast cancer in North America. J Clin Oncol 5:1870-1879, 1997.
3. Schwella N, Zimmermann R, Heuft HG, et al: Micro biologic contamination of peripheral blood stem cell autografts. Vox Sang 67:32-35, 1994.
4. Ho AD, Glück S, Germond C, et al: Optimal timing for collections of blood progenitor cells following induction chemotherapy and granulocyte-macrophage colony-stimulating factor for autologous transplantation in advanced breast cancer. Leukemia 7:1738-1746, 1993.
5. Venturinii M, Del Mastro L, Melioli G, et al: Release of peripheral blood progenitor cells during standard dose cyclophosphamide, epidoxorubicin, 5-fluorouracil plus granulocyte colony stimulating factor for breast cancer therapy. Cancer 74:2300-2306, 1994.
6. Glück S: Autologous transplantation for patients with advanced breast cancer with emphasis on bony metastasis. Can J Oncol 5:58-62, 1995.
7. Gluck S, Germond C, Lopez P, et al: High-dose paclitaxel, cyclophosphamide and mitoxantrone followed by autologous blood stem cell support for the treatment of metastatic breast cancer: A Phase I Trial. Eur J Cancer 24:1008-1014, 1998.
8. Körbling M, Champlin R: peripheral blood progenitor cell transplantation: a replacement for marrow auto-or allografts. Stem Cells 14:185-195, 1996.
9. Glück S, Ross AA, Layton TJ, et al: Decrease in tumour cell contamination and progenitor cell yield in leukapheresis products after consecutive cycles of chemotherapy for breast cancer. Biol Blood Marrow Transplant 3:316-323, 1997.
10. Braine HG, et al: Bacterial sepsis secondary to platelet transfusion: An adverse effect of extended storage at room temperature. Transfusion 26:391-393, 1986.
11. Anderson KC, Lew MA, Gorgone BC, et al: Transfusion-related sepsis after prolonged platelet storage. Am J Med 81:405-411, 1986.
12. Reik RA, Noto TA, Fernandez HF: Safety of large-volume leukapheresis for collection of peripheral blood progenitor cells. J Clin Apheresis 12:10-13, 1997.
13. NIH Workshop on Bacterial Contamination of Blood components, Sept. 1995. CBC Newsletter Oct. 13, p. 14, 1995.
14. Yomtovian R, Lazarus HM, Goodnough LT, et al: A prospective microbiologic surveillance program to detect and prevent the transfusion of bacterially contaminated platelets. Transfusion 33: 902-909, 1993.
15. Davda RK, Collins KA, Kitchens CS: Case report: Fatal Staphylococcus aureus sepsis from single-donor platelet transfusion. Am J Med Sci 307:340-341, 1994.
16. Morrow JF, Braine HG, Kickler TS: Septic reactions to platelet transfusions: A persistent problem. JAMA 266:555-558, 1991.
17. Goldman M, Blajchman MA: Blood product-associated bacterial sepsis. Transfus Med Rev 5:73-83, 1991.
18. Illert WE, Sänger W, Weise W: Bacterial contamination of single-donor blood components. Trans Med 5:57-61, 1995.
19. Blajchman MA, Ali AM: Bacteria in the blood supply: An overlooked issue in transfusion medicine. In Nance SJ (ed): "Blood Safety: Current Challenges." Bethesda, MD: American Association of Blood Banks, 1992.
20. Cohen A, Tepperberg M, Waters-Pick B, et al: The significance of microbial cultures of the haematopoietic support for patients receiving high-dose chemotherapy. J Hematother 5:289-294, 1996.
21. Dumont Larry: Bacterial contamination of platelet components. Blood Component Technol 9:4-7, 1996.
22. Buchholz DH, et al: Effects of white cell reduction on the resistance of blood components to bacterial multiplication. Transfusion 34:852-857, 1994.
23. Högman CF, et al: White cells protect donor blood against bacterial contamination. Transfusion 31:620-626, 1991.
24. Attarian H, Bensinger WI, Buckner CD, et al: Microbial contamination of peripheral blood stem cell collections. Bone Marrow Transplant 7:699-702, 1996.
25. Henslee J, Kenyon P, Ferrieri P, et al: Prevention of early gram positive (gm+) septicemia in autologous bone marrow transplant (ABMT) patients (PTS). Proc ASCO, 100:C-390, 1984.
26. S. Glück, Porter K., Dietz G. et al: Apheresis yield of haematopoietic progenitor/stem cells using different growth factors (GF). 5th Int. Congress of the World Apheresis Assoc. 22, 1994.
27. Rowley SD, Davis J, Dick J, et al: Bacterial contamination of bone marrow grafts intended for autologous and allogeneic bone marrow transplantation. Transfusion 28:109-112, 1988.
28. Hoppe PA: Interim measures for detection of bacterially contaminated red cell components. Transfusion 32:199-201, 1992.
29. Strand CL, Wajsbost RR, Sturmann K: Effect of iodophor vs. iodine tincture skin preparation on blood culture contamination rate. JAMA 269:1004-1006, 1993.
30. Walker RH, ed. Technical Manual, 11th ed. Bethesda: American Association of Blood Banks. Preparing the venipuncture site. 718, 1993.
31. Barrett BB, Anderson JW, Anderson KC: Strategies for the avoidance of bacterial contamination of blood components. Transfusion 33:228-233, 1993.
32. Anderson Kenneth C: Current trends: Evolving concepts in transfusion medicine bacterial contamination of platelets. Transfus Sci 14:159-162, 1993.
33. Glück S, Gagnon A: Neutropenic fever in patients after high-dose chemotherapy followed by autologous haematopoietic progenitor cell transplantation and human recombinant granulocyte-macrophage colony stimulating factor. Bone Marrow Transplant 14:989-990, 1994.
34. Glück S, Des Rochers C, Cano C, et al: High-dose chemotherapy followed by autologous blood cell transplantation: A safe and effective outpatient approach. Bone Marrow Transplant 6:431-435, 1997.